Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES VGS AIRCRAFT HOLDING (IRELAND) LIMITED’S SUBSIDIARY VGS INVESTMENTS FIVE LIMITED
Mandate

VINGE ADVISES VGS AIRCRAFT HOLDING (IRELAND) LIMITED’S SUBSIDIARY VGS INVESTMENTS FIVE LIMITED

July 09, 2013

Vinge has advised VGS Aircraft Holding (Ireland) Limited’s subsidiaries, VGS Investments Five Limited in conjunction with the refinancing of an Airbus A319-100 aircraft, and VGS Aircraft Leasing One Limited in conjunction with the refinancing of an Airbus A320-200 aircraft.

The lender to the VGS companies is Q Aviation Finance.

VGS Aircraft Holding (Ireland) Limited is a 50/50 joint venture between Volito Aviation AB and a company within the Goldman Sachs Group.

Vinge’s team consisted of partner Henrik Ossborn and associates Johan Ragnar and Susanne Samuelsson.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026